Qube Research & Technologies LTD Pfizer Inc Call Options Transaction History

Qube Research & Technologies LTD

  • $62.3 Billion
  • Q2 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$25.26 - $29.6 $992,718 - $1.16 Million
39,300 Added 7.46%
566,400 $15.8 Million
Q1 2024

May 14, 2024
BUY
$25.89 - $29.73 $9.23 Million - $10.6 Million
356,500 Added 208.97%
527,100 $14.6 Million
Q4 2023

Feb 13, 2024
BUY
$26.13 - $33.94 $1.35 Million - $1.75 Million
51,600 Added 43.36%
170,600 $4.91 Million
Q3 2023

Nov 13, 2023
BUY
$32.09 - $37.51 $3.82 Million - $4.46 Million
119,000 New
119,000 $3.95 Million
Q4 2022

Feb 14, 2023
BUY
$41.75 - $54.5 $8.35 Million - $10.9 Million
200,000 New
200,000 $10.3 Million

Others Institutions Holding PFE

# of Institutions
3,253
Shares Held
3.72B
Call Options Held
73.5M
Put Options Held
108M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email